Request for Information (RFI) - Atropine and Pralidoxime Chloride Injection, single dose auto-injectors
Closed Pre-Solicitation Posted
- Solicitation number
- SNS-RFI-4152024
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) is seeking information from vendors on their capability to provide FDA-approved Atropine and Pralidoxime Chloride Injection, single dose auto-injectors. The required product specifications include a 2.1mg/0.7ml dose of atropine and a 600mg/2mg(300mg/ml) dose of pralidoxime chloride. This Request for Information (RFI) is for market research purposes only and does not constitute a solicitation or promise of a future contract. Vendors are requested to provide detailed business information, respond to capability questions, and include a rough cost estimate by 2:00 PM ET on Tuesday, April 23, 2024.
This is a pre-solicitation notice for the same requirement under Solicitation Number SNS-RFI-4152024. The RFI is not set aside for any specific business category. The relevant NAICS code is likely 325412 - Pharmaceutical Preparation Manufacturing, and the PSC code is likely 6505 - Drugs and Biologicals. The RFI does not provide any information on potential incumbent contractors or estimated award values.
Notice text
The Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) is seeking information on vendor’s availability to provide acceptable pharmaceuticals of Atropine and Pralidoxime Chloride Injection, single dose auto-injectors that delivers 2.1mg/0.7ml atropine and 600mg/2mg(300mg/ml) pralidoxime chloride. SNS requires that all pharmaceuticals are FDA approved.
Files
| File | Type | Posted |
|---|---|---|
| RFI_Atropine and Pralidoxime Chloride Injection _ 4-2024 1.docx | DOCX document | |
| Atropine and Pralidoxime Chloride Injection RFI - Attachment A.xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Atropine Auto-Injector | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity